Back to search

Article

Atrial Septal Defect Device Closure in Patients with Metabolic Diseases or Genetic Syndromes

2021-12-09

Abstract excerpt

Concomitant metabolic or genetic syndromes can make atrial septal defect device closure difficult. We searched our database and found eight. The cohort consists of patients with different metabolic and genetic disease . Thromboembolic events and device embolization occurred in some patients. Careful attention is recommended in patients with special diseases.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
43b2234f-b974-549e-926e-dd52fba0c8fb
DOI
10.22541/au.163907167.75800562/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Atrial Septal Defect Device Closure in Patients with Metabolic Diseases or Genetic SyndromesDOI 10.22541/au.163907167.75800562/v1
Select a neighboring publication to make it the new centre.